Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
Allyn PR, et al. Int J STD AIDS. 2018;29(4):334-340.
Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP, et al. J Am Pharm Assoc (2003). 2016;56(6):670-676.
A regional analysis of hepatitis C virus collaborative care with pharmacists in Indian health service facilities.
Geiger R, et al. J Prim Care Community Health. 2018;9:1-5.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY, et al. J Am Pharm Assoc (2003). 2017;57(suppl 3):S259-S264.
Hepatitis C point-of-care screening in retail pharmacies in the United States.
Kugelman M, et al. Gastroenterol Hepatol. 2017;13(2):98-104.
Optimizing hepatitis C virus treatment through pharmacist interventions: identification and management of drug-drug interactions.
Langness JA, et al. World J Gastroenterol. 2017;23(9):1618-1626.
HCV testing in NSP (needle and syringe provision) community pharmacies pilot (phase 1).
Verma S, Leeman D; London Joint Working Group. Published May 2018.
Implementation of a hepatitis C collaborative drug therapy management service in an HIV ambulatory care clinic.
Sorbera M, et al. Innov Pharm. 2018;9(1).
A bitter pill to swallow: why medication safety is critical in hepatitis C treatment.
Sullivan K, et al. P T. 2018;43(12):764-768.
Hepatitis C Information Center
American Liver Foundation
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.
HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.
Hepatitis C Questions and Answers for the Public
Centers for Disease Control and Prevention (CDC; last reviewed November 2018)
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
Meeting Slides Part 2
Clinical Practice Guidelines
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases/Infectious Diseases Society of America (2018).
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention.
Harm Reduction Coalition.
HEP Drug Interactions.
University of Liverpool (last reviewed May 2019).
Action and Advocacy
Center for Health Law and Policy Innovation (CHLPI) Harvard Law School
CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.
Hepatitis C: State of Medicaid Access
CHLPI and National Viral Hepatitis Roundtable (NVHR)
Hepatitis Education Project (HEP)
HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.
National Viral Hepatitis Roundtable (NVHR)
NVHR is a coalition working to eliminate hepatitis B and C in the United States. It offers practical online resources for practice management.
Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map US Department of Health and Human Services
SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.